文献速递中毒与环境急症消化、代谢与肾脏急症

公共卫生干预与阿片类药物使用障碍者过量相关结局的模拟研究

Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder.
PubMed 文献 · JAMA Netw Open · 2024-04-01
一句话结论决策分析模型提示,直接降低过量致死风险的循证干预(如减害措施)可在短期内最大程度减少阿片类药物使用障碍者的致命过量。

该研究为决策分析模型,模拟2019至2023年美国12岁及以上阿片类药物使用障碍(OUD)人群,参数基于2019至2020年数据校准,评估2021至2023年实施的公共卫生干预与过量相关结局的关联。基线情景下,2023年预计超过1600万OUD者未接受OUD药物(MOUD)治疗、近170万接受MOUD治疗;2021至2023年预计超过500万次非致命和超过14.5万次致命阿片类药物过量。将过量率降低50%的干预组合可使非致命和致命过量分别减少至多35.2%和36.6%;针对未接受MOUD者的干预减少过量数最多;增加MOUD启动和减少OUD复发的组合可使OUD患病率降低至多23.4%、MOUD患病率增加至多137.1%,非致命和致命过量分别减少6.7%和3.5%。作者认为,扩大直接降低过量致死风险的循证干预(如减害措施)可能在短期内最大程度减少致命过量,而增加MOUD启动和维持的干预可能需要更长时间才能显著减少过量。

要点

  • 基线情景下,模型预测2023年超过1600万OUD者未接受MOUD治疗,近170万接受MOUD治疗。
  • 2021至2023年预计超过500万次非致命和超过14.5万次致命阿片类药物过量。
  • 将过量率降低50%的干预组合可使非致命过量减少至多35.2%、致命过量减少至多36.6%。
  • 针对未接受MOUD者的干预在减少非致命和致命过量数上效果最大。
  • 增加MOUD启动和减少OUD复发的组合可使OUD患病率降低至多23.4%、MOUD患病率增加至多137.1%,非致命和致命过量分别减少6.7%和3.5%。

适用人群与场景

  • 美国12岁及以上阿片类药物使用障碍(OUD)人群的模拟估计人群。

研究设计与关键结果

  • 研究类型:决策分析模型,使用2019年1月至2023年12月开发和分析的模拟模型,参数基于2019至2020年数据校准,模拟2021至2023年实施的公共卫生干预。
  • 基线情景(2019至2020年参数保持不变):2023年预计超过1600万OUD者未接受MOUD治疗,近170万接受MOUD治疗;2021至2023年预计超过500万次非致命和超过14.5万次致命阿片类药物过量。
  • 模拟将过量率降低50%的干预组合:非致命过量减少至多35.2%,致命过量减少至多36.6%。
  • 针对未接受MOUD者的干预在减少非致命和致命过量数上效果最大。
  • 增加MOUD启动和减少OUD复发的干预组合:OUD患病率降低至多23.4%,MOUD患病率增加至多137.1%,非致命过量减少6.7%,致命过量减少3.5%。

证据类型、等级与局限

  • 证据类型:决策分析模型研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,扩大直接降低OUD者过量致死风险的循证干预(如减害措施)可能在短期内最大程度减少致命过量。
  • 作者认为,旨在增加MOUD启动和治疗维持的干预可能显著改善MOUD和OUD患病率,但可能需要更长时间才能显著减少阿片类药物过量。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Given the high number of opioid overdose deaths in the US and the complex epidemiology of opioid use disorder (OUD), systems models can serve as a tool to identify opportunities for public health interventions.

OBJECTIVE: To estimate the projected 3-year association between public health interventions and opioid overdose-related outcomes among persons with OUD.

DESIGN, SETTING, AND PARTICIPANTS: This decision analytical model used a simulation model of the estimated US population aged 12 years and older with OUD that was developed and analyzed between January 2019 and December 2023. The model was parameterized and calibrated using 2019 to 2020 data and used to estimate the relative change in outcomes associated with simulated public health interventions implemented between 2021 and 2023.

MAIN OUTCOMES AND MEASURES: Projected OUD and medications for OUD (MOUD) prevalence in 2023 and number of nonfatal and fatal opioid-involved overdoses among persons with OUD between 2021 and 2023.

RESULTS: In a baseline scenario assuming parameters calibrated using 2019 to 2020 data remained constant, the model projected more than 16 million persons with OUD not receiving MOUD treatment and nearly 1.7 million persons receiving MOUD treatment in 2023. Additionally, the model projected over 5 million nonfatal and over 145 000 fatal opioid-involved overdoses among persons with OUD between 2021 and 2023. When simulating combinations of interventions that involved reducing overdose rates by 50%, the model projected decreases of up to 35.2% in nonfatal and 36.6% in fatal opioid-involved overdoses among persons with OUD. Interventions specific to persons with OUD not currently receiving MOUD treatment demonstrated the greatest reduction in numbers of nonfatal and fatal overdoses. Combinations of interventions that increased MOUD initiation and decreased OUD recurrence were projected to reduce OUD prevalence by up to 23.4%, increase MOUD prevalence by up to 137.1%, and reduce nonfatal and fatal opioid-involved overdoses among persons with OUD by 6.7% and 3.5%, respectively.

CONCLUSIONS AND RELEVANCE: In this decision analytical model study of persons with OUD, findings suggested that expansion of evidence-based interventions that directly reduce the risk of overdose fatality among persons with OUD, such as through harm reduction efforts, could engender the highest reductions in fatal overdoses in the short-term. Interventions aimed at increasing MOUD initiation and retention of persons in treatment projected considerable improvement in MOUD and OUD prevalence but could require a longer time horizon for substantial reductions in opioid-involved overdoses.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Nataraj N, Rikard SM, Zhang K, et al. Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder. JAMA Netw Open. 2024. PMID: 38568691. doi:10.1001/jamanetworkopen.2024.4617

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。